Roger G. Worthington P.C.   |   800.831.9399  |  Search  
   
Helping Asbestos Victims Get Justice in the Courtrooms and Help in the Hospitals since 1990.

Expand All | Contract All Empower Yourself: Free Medical/Legal Guide

-PATIENT PROFILES -California State Rock -Empower Yourself -PHLBI -Mesothelioma -Meso Causation -Meso Diagnosis -Treatment Options -Treatment Centers -Litigation -Settlements/Verdicts -Patient Advocacy -Asbestos Products -Legislative Updates -Meso Hotspots -Lung Cancer -Why You Need RGWPC -Web Links
 
 

Listen to Dr. Cameron speak about his surgery plus interferon trial
Click here

 

Free Legal and Medical Packet

Click Here
1- 800-831-9399

 

THE REAL DEAL

Meso lawyers since 1996.
First on the Internet.
First to post treatment options.

BEWARE OF FAKES

 
 

 

Mesothelioma Science News
January 10, 2008

 

Mesothelioma Science News
 
San Pedro, CA - January 10, 2008
  1. Peritoneal mesothelioma: surgery and intraperitoneal hyperthermic chemotherapy show promise in selected patients in Israel
     
  2. Peritoneal mesothelioma survival improves with surgery plus intraperitoneal chemotherapy in patients in France
     
  3. Peritoneal mesothelioma survival increased with surgery and intra-peritoneal hyperthermic chemotherapy in selected patients in Italy
     
  4. EPP patients have highest percentage of major complications, median survival of 16 months
     
  5. Carboplatin-pemextrexed chemotherapy in Italian pleural mesothelioma yields 14-month median survival
     
  6. New monoclonal antibody with an affinity for human mesothelin may prevent adhesion of mesothelin-bearing tumor cells and may elicit cell-mediated cytotoxicity on mesothelin-bearing tumor cells
     
  7. Combined PET-CT scanning is better for treatment and therapy of pleural mesothelioma than CT scanning alone
     
  8. Key peptide is an important marker for mesothelioma in asbestos-exposed patients
     
  9. Independent factors of stage of disease, histology type, time since diagnosis, pain, and appetite loss may be prognostic factors in patients with advanced MPM
     
  10. Study of 397 patients shows significant predictors of survival include performance status, platelet count, histology, and degree of involvement of pleural cavity rather than multimodality therapy
     
  11. Podoplanin a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin
     
  12. Pleuropneumonectomy not required for rare cases of localized (as opposed to diffuse) pleural mesothelioma
     
  13. Low exposure to chrysotile causes production of cytokines that lead to development of fibers in lungs
     
  14. Environmental exposure to waste asbestos causes pleural mesothelioma
     
  15. Asbestos industry's smear campaign against advocate who exposed their cover-up of asbestos dangers
     
  16. Tumor growth in long and short-term pleural mesothelioma survivors affected by certain proteins
     
  17. U.S. incidence of mesothelioma is 1.1 cases per 100,000 people
     
  18. High rates of mesothelioma among women and girls exposed to asbestos in Western Australia
     
  19. Environmental sampling in city of Thetford Mines indicates serious asbestos threat to public health
     
  20. Risk model being developed to predict lung cancer and mesothelioma
     
  21. Counting techniques undercount the presence of chrysotile when monitoring airborne fibers
 
site map   free brochure   disclaimer   800.831.9399   contact us   home